Samuel Gershon Junior Investigator Awards

Dr. Samuel GershonIn an ongoing effort to recognize the outstanding work of future leaders in the field, the International Society for Bipolar Disorders (ISBD), will again offer the Samuel Gershon Junior Investigator Awards to up to four young investigators for their original research publication submissions.  The Award is named in honor of Dr. Samuel Gershon, an early pioneer of lithium research who brought lithium from Australia to the United States. He was a founding member of the ISBD, the first elected president of the organization, and is Co-Editor of Bipolar Disorders: An International Journal of Psychiatry and Neurosciences. Since its inception, he has maintained an active role in the awards process and currently serves on the ISBD Awards Committee.  This year’s awards will be presented in conjunction with the 17th Annual Conference of the International Society for Bipolar Disorders in Toronto, Canada from 3-6 June 2015.  

Eligibility: These awards are open to psychiatric trainees, postgraduate students, and junior faculty up to and including the Assistant Professor rank from around the world, independent of age, nationality, sex, or race. Previous Gershon Award winners are not eligible to apply. 

The Awards: In order to promote research interest in bipolar disorder in developing countries, two of the awards will be reserved for those from low and middle-income countries, as defined by the 2014 World Bank Classification. The awards, which are contingent upon attendance at the Toronto meeting in 2015, will consist of 

  • Economy air travel up to $1,500 to be reimbursed by ISBD upon proof of purchase
  • Three nights lodging based on single occupancy conference booking rates at a hotel organized by ISBD
  • An award plaque
  • Waived registration fees for the 17th Annual Conference of the International Society for Bipolar Disorders. 

Awards will be based on the originality of the content, as well as the significance of the findings reported, and will be evaluated by an international scientific panel under the auspices of the ISBD. The applicant’s potential for long-term commitment and contributions to the field of bipolar disorder will also be evaluated. All panel decisions will be final. 

Developing Country Criteria: In order for your application to qualify as a developing country submission, a statement from an advisor/mentor certifying that the research was conducted in a developing country must be submitted with your application.  This statement may be contained in the letter of support requested in the “Application Instructions” on the application page. 

 Educational Component: After an initial review by the Awards Committee, a subset of applicants will be shortlisted and will receive a full peer-review of their manuscript by the ISBD. These reviews are intended to help applicants prepare their manuscripts for submission to a peer-reviewed English language journal. Please note, the award results have no bearing on a publication decision by the Bipolar Disorders Journal 

 Award Presentation: Winners will be expected to present their paper in an oral session at the ISBD meeting in Toronto. 

 Applications were due on September 22, 2014 and are currently under review. 

Please contact Christina Paternoster at with any questions. 

2014  Award Winners

Gershon award winners

 Pictured from left to right: Willem Nolen, Gislaine Reus,  Fernando Goes, Manuel Sanchez de Carmona, Gin Malhi, Manpreet Singh, and Cecilia Berlanga


Gershon Award Cecelia         Gershon Award Fernando

Cecilia Berlanga                                                    Fernando Goes


Gershon Award Gislaine         Gershon Award Manpreet

Gislaine Reus                                                       Manpreet Singh



Previous Awardees



Manpreet Kaur Singh, MD, MS,  Stanford University, Stanford, CA, USA
Manuscript: Early signs of anomalous neural functional connectivity in healthy offspring of parents with bipolar disorder

Gislaine Reus, PhD, University of Southern Santa Catarina, Criciuma, Brazil
Manuscript: Ketamine modulates behavioral and neurochemical alterations induced by stress: novel evidence for treatment of mood disorders

Cecilia Berlanga Flores, MD, Instituto Nacional de Neurologia y Neurocirugia, Mexico City, Mexico
Manuscript: Late-onset mania: white matter integrity and cognitive implications

Fernando Goes, MD, Johns Hopkins University, Baltimore, MD, USA
Manuscript: Exome sequencing in bipolar disorder: family and case control results implicate a set of ten interacting genes 




B.C.M. Haarman, MD, University Medical Center, Groningen, The Netherlands
Manuscript: Relationship Between Clinical Features and Inflammation Related Monocyte Gene Expression in Bipolar Disorder - Towards a Better Understanding of Psychoimmunological Interactions

Janardhanan C. Narayanaswamy, MD, Assistant Professor at the Department of Psychiatry at NIMHANS, Bangalore, India
Manuscript: A Study of Emotion Processing Strategies in Bipolar Disorder: Novel Evidence for the Endophenotype Status of Labeling Deficit

Samuel Sarrazin, MSc, Resident in Psychiatry, St. Anne Hospital, Paris, France
Manuscript: A Multicenter Tractography Study of White Matter Integrity in Bipolar Disorder and Effects of Psychotic Features

Samira S. Valvassori, MSc, Department of Psychiatry, University of Toronto, Toronto, Canada
Manuscript: Effects of Mood Stabilizers on the Signaling Pathways that Mediate Cell Death in an Animal Model of Mania induced by Ouabain




Rasim Diler, MD, Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Manuscript: Neural Activity During Emotion Processing in Bipolar versus Unipolar Depression in Adolescents

Jan-Marie Kozicky, BSc Honors, Graduate Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada
Manuscript: Executive function deficits and morphological brain changes in patients with bipolar I disorder following recovery from a first manic episode

Pedro Vieira da Silva Magalhães, MD, PhD, Post-doctoral Research Fellowship, National Institute for Translational Medicine, Hospital de Clínicas de Porto Alegre, RS, Brazil 
Manuscript: A nested population-based case-control study on peripheral inflammation markers and brain-derived neurotrophic factor in early-stage mood disorders

Cristian Zeni, MD, MSc, Department of Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Manuscript: BDNF in Juvenile Bipolar Disorder and ADHD: differentiation using BDNFserum levels, and Val66Met Polymorphism




Jigar Jogia, PhD, Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, United Kingdom, for his manuscript: Frontopolar Cortical Inefficiency Underpins Reward and Working Memory Dysfunction in Bipolar Disorder

Robin Nusslock, PhD, Department of Psychology, Northwestern University, Evanstown, Illinois, United States, for his manuscript: Waiting to win: Elevated striatal and orbitofrontal cortical activity during reward anticipation in euthymic bipolar adults

Guillermo Pérez Algorta, PhD, Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States, for his manuscript: An Inexpensive Family Index of Risk for Mood Issues Improves Identification of Pediatric Bipolar Disorder

Naren Rao, MD, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India, for his manuscript: Antithetical Relative Emotional Interference in Bipolar Disorder And Schizophrenia: An Optimized Emotional Stroop Study



Brisa Fernandes, MD, MSc, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, for her manuscript: Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis

Mauricio Kunz, MD, University of British Columbia, Vancouver, Canada, for his manuscript:Brain-derived neurotrophic factor and inflammatory markers as predictors of outcome in bipolar disorder: prospective data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)

Adriene Rosa, PhD, Bipolar Disorders Program, Clinic Hospital of Barcelona, Barcelona, Spain, for her manuscript: Functional Impairment and Disability across Mood States in Bipolar Disorder

Vesile Senturk, MD, MSc, Department of Psychiatry, Ankara University School of Medicine, Ankara, Turkey, for her manuscript: Cognitive profile of euthymic patients with bipolar disorder on monotherapy with novel antipsychotics or mood stabilizers




Ana Andreazza, PhD, Department of Psychiatry, University of British Columbia, Vancouver, Canada, for her manuscript: Decreased Complex I Activity and Increased Oxidative-Modified Protein in the Postmortem Prefrontal Cortex of Subjects with Bipolar Disorder

David Bond, MD, Department of Psychiatry, University of British Columbia, Vancouver, Canada, for his manuscript: The Association of Weight Gain with Mood Symptoms and Functional Outcomes in First-Episode Mania Patients: Prospective 12-Month Data from the Systematic Treatment Optimization Program for Early Mania

Seetal Dodd, PhD, Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, Australia, for his manuscript: A Prospective Study of the Impact of Subthreshold Mixed States on the 24-Month Clinical Outcomes of Bipolar I Disorder or Schizoaffective Disorder

Sandip Kulkarni, MD, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India, for his manuscript: Impairment of Verbal Learning and Memory and Executive Function in Unaffected Siblings of Probands with Familial Bipolar Disorder

Fernando Neves , MD, PhD, Grupo de Estudos em Neuropsiquiatria Clínica e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, for his manuscript: Is the Serotonin Transporter Polymorphism (5-HTTLPR) a Potential Marker for Suicidal Behavior in Bipolar Disorder Patients?



Dr. Benjamin I. Goldstein MD, from the Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. His innovative work focused on substance use disorders among adolescents with bipolar spectrum disorders.

Dr. Morgan Haldane, MB, BS, BSc, MRCPsych, Section of Neurobiology of Psychosis, Institute of Psychiatry, London, United Kingdom, for his research on the impact of COMT VAL158MET genotype on neural correlates of facial affect recognition in bipolar disorder patients and unaffected siblings.

Dr. Carlos Lopez, MD, MSc, from the Department of Psychiatry, School of Medicine, Universidad De Antioquia, Medellin, Colombia, for his work entitled ‘Effect of chronicity on the cognitive performance of patients with bipolar disorder type 1’.

Dr. Samir Kumar Praharaj, MBBS, MD, DPM, from the Central Institute of Psychiatry, Kanke, Ranchi, Jharkhand, India, who explored cerebral blood flow changes and efficacy of rapid suprathreshold repetitive trans-cranial magnetic stimulation of right prefrontal cortex in bipolar mania.




Dr. Carrie Bearden, PhD - University of California, Los Angeles - Los Angeles, CA, USA
Manuscript: Evidence for Disruption in Prefrontal Cortical Functions in Juvenile Bipolar Disorder

Dr. Marcia Kauer-Sant’Anna, MD - University of British Columbia - Vancouver, BC, Canada
Manuscript: Traumatic Life Events in Bipolar Disorder: Impact on BDNF Levels and Psychopathology

Dr. Benicio Frey, MD, MSc - Federal University of Rio Grande do Sul - Porto Alegre, RS, Brazil
Manuscript: Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study

Dr. Vesile Senturk, MD - Ankara University Psychiatry Dikimevi - Ankara, Turkey
Manuscript: Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate